- Mithra grants exclusive license for Tibelia® to Mediner for commercialization in Hungary
- Tibelia® is currently marketed in a 8 countries through existing license and supply agreements
- Further Tibelia® launches anticipated in 2018
Liège, Belgium, 13 July 2018 – Mithra (Euronext Brussels: MITRA), a company dedicated to Women’s Health, today announces an exclusive license and supply agreement (LSA) with Mediner for the commercialization of Tibelia® in Hungary.